PERSPECTA

News from every angle

← Back to headlines

Replimune's Advanced Skin Cancer Drug Fails FDA Approval Again

Replimune's drug designed to treat advanced skin cancer has once again failed to receive approval from the FDA.

10 Apr, 16:12 — 10 Apr, 16:12
PostShare

Sources

Showing 1 of 1 sources
ReutersVery High138d ago

Replimune's drug for advanced skin cancer fails to win FDA nod again - Reuters

Replimune's drug for advanced skin cancer fails to win FDA nod again  Reuters

Read full article →

Related Stories

Deep Partial Lunar Eclipse Visible Across North Africa and Europe

1h ago

Global Ocean Temperatures Hit Record High Amid El Niño

12h ago

Japan to Reuse Decontaminated Fukushima Soil in Regional Cities

16h ago

AP Reports World Nearing Catastrophic Climate Events

1d ago